HIFU (High-Intensity Focused Ultrasound)

In brief: HIFU is an umbrella term for devices that use focused ultrasound; it is not one product. A responsible assessment considers the exact model, cartridge, intended use, anatomy, and individual risks together. HIFU is not equivalent to a surgical facelift, and session count, response timing, and duration vary.

Definition

HIFU stands for High-Intensity Focused Ultrasound. In aesthetic medicine, the term is used for devices that deliver ultrasound energy to selected focal points beneath the skin surface. Energy distribution, nominal depth, imaging capability, and dosing logic vary by system and cartridge. Saying that someone will receive “HIFU” therefore does not identify the device, cartridge, or intended use.

Some systems aim to create controlled thermal-coagulation points followed by tissue remodelling. Clinical response is not uniform. Skin thickness, fat distribution, degree of laxity, skeletal support, age-related volume change, previous procedures, and technique may all affect the outcome. HIFU does not replace missing volume, remove excess skin, or reproduce the anatomical repositioning achieved by surgery.

How Regulatory Status Should Be Read

The category-level statement “HIFU technology is FDA approved” is inaccurate. FDA decisions apply to a named manufacturer, device model, and intended use. FDA records for the Ulthera System include K072505/DEN080006 for non-invasive eyebrow lifting, K121700 for lifting lax submental and neck tissue, and K134032 for improving lines and wrinkles of the décolleté. Those decisions do not automatically extend to another brand, cartridge, body area, or claim.

In Türkiye, verification should likewise be performed against the exact model. The Product Tracking System (ÜTS) can be used to search product and company records. A listing does not by itself prove every cartridge, anatomical area, or promotional claim. Patients may ask for the manufacturer, model, serial number, cartridge, maintenance or calibration record, and intended use before treatment.

How It Is Performed

Planning begins with an in-person medical assessment. The physician reviews the concern, anatomy at rest and in motion, tissue thickness, distribution of laxity and volume loss, previous fillers or energy-based procedures, implants, medicines, and the ability to attend follow-up. Standardised photographs may help compare baseline findings with later reviews.

If treatment is considered appropriate, the area is mapped, coupling gel is applied, and a cartridge compatible with the exact device is selected. Some systems provide ultrasound visualisation before or during treatment; this feature is not present in every HIFU device. Treatment lines, energy, and depth should not be copied from a universal online template. Comfort, relevant nerve pathways, and tissue response are monitored, while device, cartridge, and treatment details are documented.

Indications

Focused ultrasound may be considered, where the exact device and intended use support it, for selected patients with mild or moderate laxity affecting areas such as the face, brow region, submental area, jawline, neck, or décolleté. An indication combines the examination finding with the intended use of the named model; patient demand alone is not an indication.

HIFU may not be the primary option when volume loss, marked excess skin, muscle activity, surface texture, or pigmentation is the main concern. A different device, an injectable treatment, skincare, observation, or a surgical opinion may be more appropriate. The presence of several concerns does not mean that every modality should be used or performed at the same visit.

Contraindications and Reasons to Defer

Treatment is deferred when there is active infection, an open wound, or unexplained inflammation in the intended area. Because safety evidence for elective aesthetic energy procedures during pregnancy and breastfeeding is limited, postponement is generally the more cautious approach. An implanted electronic device, metal or dental implant, sensory or neurological disorder, recent procedure, bleeding risk, immune condition, or regular medicine may alter whether, where, or how treatment is considered.

Marked excess skin, substantial facial fat loss, unrealistic expectations, or inability to attend follow-up may also lead to a decision not to treat. This list is educational and cannot establish individual candidacy remotely.

Timing and Recovery

Temporary redness, tenderness, swelling, tingling, or numbness may occur. Return to routine varies with the person, area, and treatment intensity. Early swelling or temporary firmness should not be interpreted as the final outcome.

Focused-ultrasound studies use different devices, protocols, follow-up points, and outcome measures. Systematic reviews report measured improvement in selected patients with mild or moderate laxity, while also noting heterogeneous methods and more limited long-term evidence. It is therefore inappropriate to promise one session for everyone, a outcomes that vary by person by a fixed date, or a fixed duration. The review point follows the device protocol and individual tissue response; any repeat treatment decision should be based on examination and follow-up documentation.

Risks and Side Effects

Commonly reported early effects include redness, swelling, tenderness, and procedural pain. Bruising, temporary altered sensation, or prolonged tenderness may occur less often. Burns, linear marks, scarring, fat atrophy, and neurological symptoms have also been reported in the literature and post-market records. A risk being uncommon does not mean that it is absent.

Increasing or persistent severe pain, blistering or a burn-like change, unusual skin-colour change, new marked asymmetry, muscle weakness, widespread numbness, or another neurological symptom requires prompt in-person medical assessment. A photograph may help with first contact but cannot replace examination or urgent care when indicated.

Comparison

HIFU, RF microneedling, monopolar radiofrequency, threads, fillers, and surgical facelift are not interchangeable. HIFU uses focused ultrasound. RF microneedling combines needles with radiofrequency and may be considered more for texture or scar-related goals. Fillers provide volume support, threads provide mechanical support, and surgery can directly address excess skin and deeper structures.

The useful question is not simply “which device is strongest?” but “which anatomical finding is dominant, and which option is proportionate to that finding and the patient's risk and recovery preferences?” Avoiding an unnecessary procedure and not presenting a device as equivalent to surgery are part of safe care.

Consultation Checklist

• What are the manufacturer and exact model of the device?
• Can the serial number, cartridge, maintenance, and calibration records be identified?
• Is the planned area included in the model's intended use?
• Is my main issue laxity, volume loss, surface texture, or another diagnosis?
• What can HIFU not achieve, and what reasonable alternatives exist?
• Which symptoms are expected, and which require prompt review?
• How will follow-up be timed, and what finding would justify another procedure?

References

This entry is based on device-specific FDA decisions, Türkiye's Product Tracking System, and systematic reviews indexed in PubMed. Regulatory records can change; the current status of the exact model intended for treatment should be checked at the time of care.

Content updated: 2 August 2026 · Medical review: Dr. Hamza Gemici